Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-06-13

FDA Approved: PITAVASTATIN — Supplemental Application (Teva Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved a supplemental application for pitavastatin calcium by Teva Pharmaceuticals, updating/expanding the existing approval for this generic statin produ…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PITAVASTATIN CALCIUM (PITAVASTATIN CALCIUM)

Snippet

SUPPL AP for PITAVASTATIN (PITAVASTATIN CALCIUM)